5Lee R,Neya K,Svizzero TA,et al.Norepinephrine infusion following cardiopulmonary bypass:effect of infusion site[].Journal of Surgical Research.1995
6Kawamura T,Nara N,Kadosaki M,et al.Prostagladin E1 reduces myocardial reperfusion iujury by inhibiting proinflammatory cytokines production during cardiac surgery[].Critical Care Medicine.2000
7Shafique T,Johnso RG,Dai HB,et al.Altered pulmonary micr-ovascular reactivity after total cardiopulmonary bypass[].Journal of Thoracic and Cardiovascular Surgery.1993
8Dawson CA,Cozzini BO,Lonigro A J.Metabolism of prostagladin E1 on passage through the pulmonary circulation[].Canadian Journal of Physiology and Pharmacology.1975
9Komai H,Yamamoto F,Tanaka K,et al.Increased lung injury in pulmonary patients during open heart operations[].The Annals of Thoracic Surgery.1993
10Tritapepe L,Voci P,Cogliati AA,et al.Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension[].Critical Care Medicine.1999
